Long-term Change in Physiological Markers and Cognitive Performance in Type 2 Diabetes: The Look AHEAD Study

Author:

Carmichael Owen T1ORCID,Neiberg Rebecca H2,Dutton Gareth R3,Hayden Kathleen M4,Horton Edward5,Pi-Sunyer F Xavier6,Johnson Karen C7,Rapp Stephen R8,Spira Adam P9,Espeland Mark A10

Affiliation:

1. Biomedical Imaging Center, Pennington Biomedical Research Center, Baton Rouge, Louisiana

2. Department of Biostatistics and Data Science, Wake Forest School of Medicine, Winston-Salem, North Carolina

3. Department of Medicine, Division of Preventive Medicine, University of Alabama at Birmingham, Birmingham, Alabama

4. Social Sciences and Health Policy, Wake Forest School of Medicine, Winston-Salem, North Carolina

5. Joslin Diabetes Center, Harvard University, Boston, Massachusetts

6. Division of Endocrinology, Obesity/Nutrition Research Center, Columbia University College of Physicians and Surgeons, New York, NY

7. Department of Preventive Medicine, The University of Tennessee Health Science Center, Memphis, Tennessee

8. Department of Psychiatry & Behavioral Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina

9. Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD

10. Division of Gerontology and Geriatric Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina

Abstract

Abstract Context The effects of physiological improvements on cognitive function among persons with type 2 diabetes mellitus (T2DM) are not fully understood. Objective To determine whether improvements in physiological markers (body weight, blood sugar control, and physical activity) during intensive lifestyle intervention (ILI) are associated with enhancements in cognitive function in older adults with T2DM. Design Multisite randomized controlled trial. Setting Academic research centers. Patients or Other Participants Participants were aged 45–76 years, with T2DM. Intervention The Action for Health in Diabetes (Look AHEAD) study, a randomized, controlled clinical trial of ILI. Main Outcome Measure Two to 3 cognitive assessments were collected from 1089 participants, the first and last occurring a mean (standard deviation) of 8.6 (1.0) and 11.5 (0.7) years after enrollment. Results Greater improvement in blood sugar control was associated with better cognitive scores (fasting glucose and Rey Auditory Verbal Learning Test [AVLT]: P = 0.0148; fasting glucose and Digit Symbol Coding (DSC): P = 0.0360; HbA1C and DSC: P = 0.0477); but weight loss had mixed associations with cognitive scores (greater body mass index [BMI] reduction and worse AVLT overall: P = 0.0053; and greater BMI reduction and better DSC scores among those overweight but not obese at baseline: P = 0.010). Associations were strongest among those who were overweight (not obese) at baseline, and among those with a history of cardiovascular disease (CVD) at baseline. Conclusions Improvements in glycemic control, but not necessarily weight status, during ILI may be associated with better subsequent cognitive performance. These associations may differ by adiposity and CVD history.

Funder

National Institutes of Health

National Institute of Diabetes and Digestive and Kidney Diseases

National Heart, Lung, and Blood Institute

National Institute of Nursing Research

National Center on Minority Health and Health Disparities

Office of Research on Women's Health

Centers for Disease Control and Prevention

Johns Hopkins Medical Institutions Bayview General Clinical Research Center

Massachusetts General Hospital Mallinckrodt General Clinical Research Center

Massachusetts Institute of Technology General Clinical Research Center

Harvard Clinical and Translational Science Center

University of Colorado Health Sciences Center General Clinical Research Center

Clinical Nutrition Research Unit

University of Tennessee at Memphis General Clinical Research Center

University of Pittsburgh General Clinical Research Center

Clinical Translational Research Center

U.S. Department of Veterans Affairs

Frederic C. Bartter General Clinical Research Center

Publisher

The Endocrine Society

Subject

Biochemistry (medical),Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3